$100 billion market cap is the blue-sky scenario for Moderna, analyst says

Moderna, a forerunner in the development of coronavirus vaccines, has the potential to reach a $100 billion-plus market capitalization, according to an analyst.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.